AI is a viable alternative to high throughput screening: a 318-target study

Jon M. Sorenson(United States Department of the Navy), Desiree A. Thayer(Healthwise), Saulo de Oliveira(Healthwise), Niel M. Henriksen(Healthwise), Nicholas J. Anthis(Healthwise), Krishna K. Sarangapani(Healthwise), Denzil Bernard(Healthwise), Kate A. Stafford(Healthwise), Victor Kenyon(Amgen (United States)), Greg Friedland(Healthwise), Andreana M. Rosnik(Healthwise), Paweł Gniewek(Healthwise), Henry van den Bedem(Healthwise), Stephanie R. Hare(Healthwise), Ehsan Moharreri(Healthwise), Ting‐Rong Chern(Healthwise), Brittany Butler(Healthwise), Kyle E. Giesler(Healthwise), Teresa A. Palazzo(Healthwise), Jeffrey M. Warrington(Q Therapeutics (United States)), Adrian Stecuła, Tessa Van Grack(Healthwise), Mostafa Ahmed(Healthwise), Terrence E. O’Brien(University of California, Davis), Tiffany R. Williams(Healthwise), Izhar Wallach(Healthwise), Michael M. Mysinger(Healthwise), Bryan D. Cox(World Vision), Stephanie Contreras(Healthwise), Ha H. Truong(Commonwealth Scientific and Industrial Research Organisation), Brandon Anderson(San Mateo County Health System), Lien Ngo(Healthwise), Srimukh Veccham Krishna PrasadPrasad(Healthwise), Stefani Shek(Healthwise), Ho Leung Ng(Healthwise), Ann O’Sullivan(Healthwise), Aram Davtyan(Healthwise), Shabbir Suterwala(Healthwise), Adrian R. Morrison(Healthwise), Ben Samudio(Healthwise), Bill Thomas(Healthwise), Andrew B. Cann(OpenAI (United States)), Bastiaan Bergman, Gregory Ho(Healthwise), Kong T. Nguyen(Healthwise), Brad Worley(Healthwise), Andreia H. Lee(Amgen (United States)), Christian Laggner(Healthwise), S.R. Eckert(Healthwise)
Scientific Reports
April 2, 2024
Cited by 121


Related Papers